Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nuclear Receptor ROR-Gamma market report explains the definition, types, applications, major countries, and major players of the Nuclear Receptor ROR-Gamma market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Brickell Biotech Inc
Biogen Inc
Lead Pharma Holding BV
Aurigene Discovery Technologies Limited
Arrien Pharmaceuticals, LLC
Vitae Pharmaceuticals Inc
Bristol-Myers Squibb Company
Genfit SA
Visionary Pharmaceuticals Inc
Nuevolution AB
GlaxoSmithKline Plc
Genentech Inc
Celgene Corporation
Hanmi Pharmaceuticals, Co Ltd
Karo Bio AB
Advinus Therapeutics Ltd
Phenex Pharmaceuticals AG
Reata Pharmaceuticals Inc
Teijin Pharma Limited
4SC AG
By Type:
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
By End-User:
Hospital
Clinic
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Nuclear Receptor ROR-Gamma Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Nuclear Receptor ROR-Gamma Outlook to 2028- Original Forecasts
-
2.2 Nuclear Receptor ROR-Gamma Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Nuclear Receptor ROR-Gamma Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Nuclear Receptor ROR-Gamma Market- Recent Developments
-
6.1 Nuclear Receptor ROR-Gamma Market News and Developments
-
6.2 Nuclear Receptor ROR-Gamma Market Deals Landscape
7 Nuclear Receptor ROR-Gamma Raw Materials and Cost Structure Analysis
-
7.1 Nuclear Receptor ROR-Gamma Key Raw Materials
-
7.2 Nuclear Receptor ROR-Gamma Price Trend of Key Raw Materials
-
7.3 Nuclear Receptor ROR-Gamma Key Suppliers of Raw Materials
-
7.4 Nuclear Receptor ROR-Gamma Market Concentration Rate of Raw Materials
-
7.5 Nuclear Receptor ROR-Gamma Cost Structure Analysis
-
7.5.1 Nuclear Receptor ROR-Gamma Raw Materials Analysis
-
7.5.2 Nuclear Receptor ROR-Gamma Labor Cost Analysis
-
7.5.3 Nuclear Receptor ROR-Gamma Manufacturing Expenses Analysis
8 Global Nuclear Receptor ROR-Gamma Import and Export Analysis (Top 10 Countries)
-
8.1 Global Nuclear Receptor ROR-Gamma Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Nuclear Receptor ROR-Gamma Export by Region (Top 10 Countries) (2017-2028)
9 Global Nuclear Receptor ROR-Gamma Market Outlook by Types and Applications to 2022
-
9.1 Global Nuclear Receptor ROR-Gamma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global VPR-66 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global INV-17 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global GSK-2981278 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global BBI-6000 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Nuclear Receptor ROR-Gamma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Nuclear Receptor ROR-Gamma Market Analysis and Outlook till 2022
-
10.1 Global Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.2.2 Canada Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.2.3 Mexico Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.2 UK Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.3 Spain Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.4 Belgium Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.5 France Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.6 Italy Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.7 Denmark Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.8 Finland Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.9 Norway Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.10 Sweden Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.11 Poland Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.12 Russia Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.3.13 Turkey Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.2 Japan Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.3 India Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.4 South Korea Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.5 Pakistan Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.6 Bangladesh Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.7 Indonesia Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.8 Thailand Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.9 Singapore Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.10 Malaysia Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.11 Philippines Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.4.12 Vietnam Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.2 Colombia Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.3 Chile Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.4 Argentina Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.5 Venezuela Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.6 Peru Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.7 Puerto Rico Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.5.8 Ecuador Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.6.2 Kuwait Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.6.3 Oman Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.6.4 Qatar Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.6.5 Saudi Arabia Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.6.6 United Arab Emirates Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.7.2 South Africa Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.7.3 Egypt Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.7.4 Algeria Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Nuclear Receptor ROR-Gamma Consumption (2017-2022)
-
10.8.2 New Zealand Nuclear Receptor ROR-Gamma Consumption (2017-2022)
11 Global Nuclear Receptor ROR-Gamma Competitive Analysis
-
11.1 Brickell Biotech Inc
-
11.1.1 Brickell Biotech Inc Company Details
-
11.1.2 Brickell Biotech Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Brickell Biotech Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.1.4 Brickell Biotech Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Biogen Inc
-
11.2.1 Biogen Inc Company Details
-
11.2.2 Biogen Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Biogen Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.2.4 Biogen Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Lead Pharma Holding BV
-
11.3.1 Lead Pharma Holding BV Company Details
-
11.3.2 Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.3.4 Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Aurigene Discovery Technologies Limited
-
11.4.1 Aurigene Discovery Technologies Limited Company Details
-
11.4.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.4.4 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Arrien Pharmaceuticals, LLC
-
11.5.1 Arrien Pharmaceuticals, LLC Company Details
-
11.5.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.5.4 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Vitae Pharmaceuticals Inc
-
11.6.1 Vitae Pharmaceuticals Inc Company Details
-
11.6.2 Vitae Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Vitae Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.6.4 Vitae Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bristol-Myers Squibb Company
-
11.7.1 Bristol-Myers Squibb Company Company Details
-
11.7.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.7.4 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Genfit SA
-
11.8.1 Genfit SA Company Details
-
11.8.2 Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Genfit SA Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.8.4 Genfit SA Nuclear Receptor ROR-Gamma Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Visionary Pharmaceuticals Inc
-
11.9.1 Visionary Pharmaceuticals Inc Company Details
-
11.9.2 Visionary Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Visionary Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.9.4 Visionary Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Nuevolution AB
-
11.10.1 Nuevolution AB Company Details
-
11.10.2 Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Nuevolution AB Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.10.4 Nuevolution AB Nuclear Receptor ROR-Gamma Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 GlaxoSmithKline Plc
-
11.11.1 GlaxoSmithKline Plc Company Details
-
11.11.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.11.4 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Genentech Inc
-
11.12.1 Genentech Inc Company Details
-
11.12.2 Genentech Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Genentech Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.12.4 Genentech Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Celgene Corporation
-
11.13.1 Celgene Corporation Company Details
-
11.13.2 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Celgene Corporation Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.13.4 Celgene Corporation Nuclear Receptor ROR-Gamma Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Hanmi Pharmaceuticals, Co Ltd
-
11.14.1 Hanmi Pharmaceuticals, Co Ltd Company Details
-
11.14.2 Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.14.4 Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Karo Bio AB
-
11.15.1 Karo Bio AB Company Details
-
11.15.2 Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Karo Bio AB Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.15.4 Karo Bio AB Nuclear Receptor ROR-Gamma Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Advinus Therapeutics Ltd
-
11.16.1 Advinus Therapeutics Ltd Company Details
-
11.16.2 Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.16.4 Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Phenex Pharmaceuticals AG
-
11.17.1 Phenex Pharmaceuticals AG Company Details
-
11.17.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.17.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Reata Pharmaceuticals Inc
-
11.18.1 Reata Pharmaceuticals Inc Company Details
-
11.18.2 Reata Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.18.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Teijin Pharma Limited
-
11.19.1 Teijin Pharma Limited Company Details
-
11.19.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.19.4 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 4SC AG
-
11.20.1 4SC AG Company Details
-
11.20.2 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 4SC AG Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
11.20.4 4SC AG Nuclear Receptor ROR-Gamma Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Nuclear Receptor ROR-Gamma Market Outlook by Types and Applications to 2028
-
12.1 Global Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global VPR-66 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global INV-17 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global GSK-2981278 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global BBI-6000 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Nuclear Receptor ROR-Gamma Market Analysis and Outlook to 2028
-
13.1 Global Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.2.2 Canada Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.2.3 Mexico Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.2 UK Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.3 Spain Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.4 Belgium Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.5 France Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.6 Italy Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.7 Denmark Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.8 Finland Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.9 Norway Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.10 Sweden Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.11 Poland Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.12 Russia Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.3.13 Turkey Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.2 Japan Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.3 India Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.4 South Korea Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.8 Thailand Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.9 Singapore Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.11 Philippines Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.2 Colombia Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.3 Chile Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.4 Argentina Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.6 Peru Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.6.3 Oman Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.6.4 Qatar Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.7.2 South Africa Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.7.3 Egypt Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.7.4 Algeria Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Nuclear Receptor ROR-Gamma Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Nuclear Receptor ROR-Gamma
-
Figure of Nuclear Receptor ROR-Gamma Picture
-
Table Global Nuclear Receptor ROR-Gamma Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Nuclear Receptor ROR-Gamma Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global VPR-66 Consumption and Growth Rate (2017-2022)
-
Figure Global INV-17 Consumption and Growth Rate (2017-2022)
-
Figure Global GSK-2981278 Consumption and Growth Rate (2017-2022)
-
Figure Global BBI-6000 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Table North America Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure United States Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Canada Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Mexico Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table Europe Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure Germany Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure UK Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Spain Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Belgium Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure France Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Italy Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Denmark Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Finland Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Norway Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Sweden Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Poland Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Russia Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Turkey Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table APAC Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure China Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Japan Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure India Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Thailand Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Singapore Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Philippines Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table South America Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure Brazil Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Colombia Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Chile Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Argentina Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Peru Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table GCC Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure Bahrain Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Oman Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Qatar Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table Africa Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure Nigeria Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure South Africa Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Egypt Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure Algeria Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table Oceania Nuclear Receptor ROR-Gamma Consumption by Country (2017-2022)
-
Figure Australia Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Nuclear Receptor ROR-Gamma Consumption and Growth Rate (2017-2022)
-
Table Brickell Biotech Inc Company Details
-
Table Brickell Biotech Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Brickell Biotech Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Brickell Biotech Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Biogen Inc Company Details
-
Table Biogen Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Biogen Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Lead Pharma Holding BV Company Details
-
Table Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Lead Pharma Holding BV Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Aurigene Discovery Technologies Limited Company Details
-
Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Arrien Pharmaceuticals, LLC Company Details
-
Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Vitae Pharmaceuticals Inc Company Details
-
Table Vitae Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vitae Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Vitae Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Bristol-Myers Squibb Company Company Details
-
Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Genfit SA Company Details
-
Table Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genfit SA Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Genfit SA Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Visionary Pharmaceuticals Inc Company Details
-
Table Visionary Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Visionary Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Visionary Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Nuevolution AB Company Details
-
Table Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nuevolution AB Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Nuevolution AB Nuclear Receptor ROR-Gamma Product Portfolio
-
Table GlaxoSmithKline Plc Company Details
-
Table GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Genentech Inc Company Details
-
Table Genentech Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Genentech Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Celgene Corporation Company Details
-
Table Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Celgene Corporation Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Hanmi Pharmaceuticals, Co Ltd Company Details
-
Table Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Hanmi Pharmaceuticals, Co Ltd Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Karo Bio AB Company Details
-
Table Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Karo Bio AB Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Karo Bio AB Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Advinus Therapeutics Ltd Company Details
-
Table Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Advinus Therapeutics Ltd Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Phenex Pharmaceuticals AG Company Details
-
Table Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Reata Pharmaceuticals Inc Company Details
-
Table Reata Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reata Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Reata Pharmaceuticals Inc Nuclear Receptor ROR-Gamma Product Portfolio
-
Table Teijin Pharma Limited Company Details
-
Table Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teijin Pharma Limited Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Portfolio
-
Table 4SC AG Company Details
-
Table 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Value and Gross Profit (2017-2022)
-
Table 4SC AG Nuclear Receptor ROR-Gamma Main Business and Markets Served
-
Table 4SC AG Nuclear Receptor ROR-Gamma Product Portfolio
-
Figure Global VPR-66 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global INV-17 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GSK-2981278 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BBI-6000 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Table North America Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure United States Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure Germany Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure China Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure Brazil Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Nuclear Receptor ROR-Gamma Consumption Forecast by Country (2022-2028)
-
Figure Australia Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Nuclear Receptor ROR-Gamma Consumption Forecast and Growth Rate (2022-2028)
-
